Research study Program year 2019 Source: CMS Open Payments

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and Impaired Systoli

ClinicalTrials.gov NCT03016325

Research payments

$968,320

22 payments

Through program year 2019, $968,320 in research payments was reported against A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and Impaired Systoli, across 22 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by: E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov: NCT03016325

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$968,320	22

Breakdown

Who paid Research payments · program year 2019

E.R. Squibb & Sons, L.L.C. $968,320 22 payments

Who received the money Research payments · program year 2019

Wayne State University Organisation paid for research $197,375 3 payments
Washington University Organisation paid for research $118,983 1 payment
Henry Ford Hospital Teaching hospital · MI $96,093 1 payment
Thomas Jefferson University Organisation paid for research $92,214 1 payment
University of Cincinnati Physicians Company LLC Organisation paid for research $83,916 1 payment
Methodist Research Institute Organisation paid for research $75,606 1 payment
Us Oncology Res Llc Organisation paid for research $65,969 1 payment
University Of Virginia Medical Cente Teaching hospital · VA $57,798 1 payment
University Of Florida Board Of Trustees Organisation paid for research $39,878 1 payment
Saint Louis University Organisation paid for research $35,986 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Cite this record

“A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Ranging, Phase 2b Study of the Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of BMS-986231 in Hospitalized Patients with Heart Failure and Impaired Systoli”, Who Paid My Doc, citing CMS Open Payments, program year 2019. https://www.whopaidmydoc.com/research-studies/a-multicenter-randomized-double-blind-parallel-group-placebo-controlled-dose-ranging-phase-2b-study-of-the-safety-and-efficacy-of-continuous-48-hour-intravenous-infusions-of-bms-986231-in-hospitalized-patients-with-heart-failure-and-impaired-systoli-373977057

Figures here may be reproduced with attribution and a link — see for journalists and researchers.